Detection of gyrA ser83 mutation and parC gene amplification in E.coli and Klebsiella pneumoniae from tertiary care hospital, Puducherry
Journal Title: IP International Journal of Medical Microbiology and Tropical Diseases - Year 2017, Vol 3, Issue 4
Abstract
Introduction: Fluoroquinolones are the broad spectrum antibiotics and recently the clinical isolates of Enterobacteriaceae species had slowly extend the high resistance towards them. The point mutation in gyrA gene had showed decreased susceptibility to ciprofloxacin and resistant to nalidixic acid. The aim of the present study was to identify gyrA and parC genes and gyrA ser83 mutation among clinical isolates of Escherichia coli and Klebsiella pneumoniae by RFLP. Methods: A total of 100 clinical strains of both Escherichia coli and Klebsiella pneumoniae were collected from tertiary care hospital from Pondicherry. All the strains were subjected to antimicrobial susceptibility pattern testing by disc diffusion method as per the Clinical Laboratory Standard Institute (CLSI2012). PCR based screening of gyrA and parC was carried out and additional analysis of gyrA ser83-phe mutation in E.coli and K.pneumoniae by agarose gel electrophoresis. Results: Variation in both ciprofloxacin and nalidixic acid resistance were showed in the (100) clinical isolates of E.coli and K. pneumoniae were reported earlier. GyrA and parC genes were detected in both susceptible and resistant isolates of E.coli and K.pneumoniae. Among them, E.coli showed 100% (50/50) and K.pneumoniae showed 84% (42/50) positivity for gyrA while 78% (39/50) and 64% (32/50) positivity for parC. PCR-RFLP results indicated gyrA ser83 mutation in 84% (42/50) of E.coli and 66% (33/50). The results also shows that E.coli is less susceptible to fluoroquinolones compared to K.pneumoniae. Conclusion: The overall resistance were increased for the ciprofloxacin and nalidixic acid among clinical isolates of E.coli and K. pneumoniae due to gyrA ser83-phe mutation. The antimicrobial resistance to fluoroquinolone drugs indicate the rapid genetic modifications undertaken by Enterobacteriaceae species and need for routine screening for resistance to develop next generation drugs.
Authors and Affiliations
G. Muthu, T. Mangaiyarkarasi, Vishnuprabu . , E. Sathishkumar, S. Srivani
Keywords
Related Articles
- EP ID EP306701
- DOI 10.18231/2455-6807.2017.0040
- Views 98
- Downloads 0
Bacteriological profile in UTI Cases with special reference to Amikacin sensitivity in a tertiary Care centre in Western UP
Introduction UTI is the most common bacterial infection worldwide with adult women being 30 times more likely to suffer from it than men due to short urethra and proximity of uretheral opening with anal canal Escherichia...
Detection of Siderophore production in Uropathogenic Escherichia.coli in patients with Type 2 Diabetes Mellitus
Introduction: Infection of the urinary tract is a common observation in patients with type 2 diabetes mellitus. UTI can be a severe complication in diabetic patients. The aim of this study was to determine siderophore pr...
Vancomycin resistant enterococci: an emerging problem in a tertiary care hospital, Pune, India
Background and Objectives: Vancomycin resistant Enterococci (VRE) have recently emerged as nosocomial pathogen with intrinsic resistance to many antimicrobial agents making them difficult to treat. We investigated the pr...
Klebsiella: An insight into the virulence factors and antimicrobial susceptibility pattern
Introduction: Klebsiella pneumoniae is a frequent pathogen isolated from pneumonia, urinary tract infections, liver abscesses, wound infections, intravascular catheter infections, biliary tract infections, peritonitis an...
Changing trend in clinico-mycological profile of dermatophytosis of skin in Eastern India
Introduction Dermatophytosis is one of the most prevalent cutaneous mycosis and a public health problem in West Bengal as well as in India Its footprint spans far and wide across urban and rural Bengal with a distributio...